Is HealthEquity Inc (HQY) overvalued? · P/E 73, rev $705.4M
HealthEquity Inc (HQY) is a health information services company listed on US.
This page asks whether HealthEquity Inc (HQY) looks expensive on cached numbers — not a short thesis.
Latest reported HQY revenue for 2026-07-31 was $705.4M. Net income was $135.1M. Revenue was up 98.9% from 2026-04-30 to 2026-07-31. HQY currently screens at market cap $8.65B and trailing P/E 73.0.
HQY currently screens at market cap $8.65B and trailing P/E 73.0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next HQY 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the HQY stock page for the full model, not this heading.
Not investment advice.